| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anna-Kaisa Försti, Jari Jokelainen, Hanna Ansakorpi, Allan Seppänen, Kari Majamaa, Markku Timonen, Kaisa Tasane. Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish Care Register study. Scientific reports. vol 6. 2018-05-16. PMID:27845416. |
the strongest risk of developing bp was found after diagnosis of multiple sclerosis (ms) (or=5.9, 95% ci 3.9-8.5). |
2018-05-16 |
2023-08-13 |
Not clear |
| Briana C Prager, Amy S Nowacki, Devon S Conwa. Survey-based assessment of the relationship between cognitive impairment and mentally stimulating activity in multiple sclerosis. Neurological research. vol 39. issue 9. 2018-04-24. PMID:28679344. |
cognitive impairment (ci) is a common and potentially debilitating component of the disease course in multiple sclerosis (ms). |
2018-04-24 |
2023-08-13 |
Not clear |
| Luis Ruano, Emilio Portaccio, Benedetta Goretti, Claudia Niccolai, Milton Severo, Francesco Patti, Sabina Cilia, Paolo Gallo, Paola Grossi, Angelo Ghezzi, Marco Roscio, Flavia Mattioli, Chiara Stampatori, Maria Trojano, Rosa Gemma Viterbo, Maria Pia Amat. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Multiple sclerosis (Houndmills, Basingstoke, England). vol 23. issue 9. 2018-04-19. PMID:27738090. |
there is limited and inconsistent information on the clinical determinants of cognitive impairment (ci) in multiple sclerosis (ms). |
2018-04-19 |
2023-08-13 |
Not clear |
| Polona Lavtar, Gorazd Rudolf, Aleš Maver, Alenka Hodžić, Nada Starčević Čizmarević, Maja Živković, Saša Šega Jazbec, Zalika Klemenc Ketiš, Miljenko Kapović, Evica Dinčić, Ranko Raičević, Juraj Sepčić, Luca Lovrečić, Aleksandra Stanković, Smiljana Ristić, Borut Peterli. Association of circadian rhythm genes ARNTL/BMAL1 and CLOCK with multiple sclerosis. PloS one. vol 13. issue 1. 2018-02-15. PMID:29324865. |
the arntl rs3789327 cc genotype was associated with higher risk for multiple sclerosis at an or of 1.67 (95% ci 1.35-2.07, p = 0.0001) and the clock rs6811520 genotype cc at an or of 1.40 (95% ci 1.13-1.73, p = 0.002). |
2018-02-15 |
2023-08-13 |
Not clear |
| Dániel Sandi, Tamás Biernacki, Dóra Szekeres, Judit Füvesi, Zsigmond Tamás Kincses, Csilla Rózsa, Klotild Mátyás, Krisztián Kása, Judit Matolcsi, Dóra Zboznovits, Zita Burány, Éva Langane, László Vécsei, Krisztina Bencsi. Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome. Multiple sclerosis and related disorders. vol 17. 2018-02-07. PMID:29055476. |
cognitive impairment (ci) is a frequent symptom of multiple sclerosis (ms); its prevalence is reported to be 43-70%. |
2018-02-07 |
2023-08-13 |
Not clear |
| J M Tillema, H E Hulst, M A Rocca, H Vrenken, M D Steenwijk, D Damjanovic, C Enzinger, S Ropele, G Tedeschi, A Gallo, O Ciccarelli, A Rovira, X Montalban, N de Stefano, M L Stromillo, M Filippi, F Barkho. Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study. Multiple sclerosis (Houndmills, Basingstoke, England). vol 22. issue 7. 2018-01-29. PMID:26432859. |
the objectives of this paper are to compare in a multicenter setting patterns of regional cortical thickness in patients with relapsing-remitting multiple sclerosis (rrms) and cognitive impairment (ci) and those cognitively preserved (cp), and explore the relationship between cortical thinning and cognitive performance. |
2018-01-29 |
2023-08-13 |
Not clear |
| Su-Hyun Kim, Kichang Kwak, In Hye Jeong, Jae-Won Hyun, Hyo-Jin Jo, AeRan Joung, Eun-Seung Yu, Ji-Hee Kim, Sang Hyun Lee, Sooin Yun, Jungnam Joo, Dong-Kyun Lee, Jong-Min Lee, Ho Jin Ki. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). vol 22. issue 14. 2018-01-26. PMID:26920380. |
to compare the frequency and pattern of cognitive impairment (ci) between patients with neuromyelitis optica spectrum disorder (nmosd) and multiple sclerosis (ms). |
2018-01-26 |
2023-08-13 |
Not clear |
| Luisa Pastò, Emilio Portaccio, Benedetta Goretti, Angelo Ghezzi, Silvia Lori, Bahia Hakiki, Marta Giannini, Isabella Righini, Lorenzo Razzolini, Claudia Niccolai, Lucia Moiola, Monica Falautano, Marta Simone, Rosa Gemma Viterbo, Francesco Patti, Sabina Cilia, Carlo Pozzilli, Valentina Bianchi, Marco Roscio, Vittorio Martinelli, Giancarlo Comi, Maria Trojano, Maria Pia Amat. The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). vol 22. issue 13. 2018-01-19. PMID:26869527. |
the study of cognitive reserve (cr) in relationship with cognitive impairment (ci) in pediatric-onset multiple sclerosis (poms) may provide cues to identifying subjects at higher risk of impairment and scope for therapeutic strategies. |
2018-01-19 |
2023-08-13 |
human |
| Praerna Bhargav, Hemant Bhargav, Nagarathna Raghuram, Christoph Garne. Immediate effect of two yoga-based relaxation techniques on cognitive functions in patients suffering from relapsing remitting multiple sclerosis: A comparative study. International review of psychiatry (Abingdon, England). vol 28. issue 3. 2018-01-04. PMID:27299568. |
cognitive impairment (ci) is an important feature of relapsing remitting multiple sclerosis (rrms). |
2018-01-04 |
2023-08-13 |
human |
| Robin Park, Won Jin Lee, Jong Dae J. Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis. Autoimmunity. vol 49. issue 7. 2017-12-22. PMID:27098222. |
the snp rs2910164 g > c was found to be associated with increased risk of multiple sclerosis (cc + cg versus gg, or = 1.25, 95% ci: 1.01-1.55), with decreased risks of psoriasis (c versus g, or = 0.81, 95% ci: 0.69-0.96; cc versus gc + gg, or = 0.73, 95% ci: 0.56-0.94), behcet's disease (cc versus gc + gg, or = 0.60, 95% ci: 0.50-0.73), asthma (c versus g, or = 0.80, 95% ci: 0.69-0.93; cc versus gc + gg, or = 0.65, 95% ci: 0.48-0.86), and uveitis (cc + cg versus gg, or = 0.61, 95% ci: 0.49-0.77). |
2017-12-22 |
2023-08-13 |
Not clear |
| Martin Alfut. Textured and stimulating insoles for balance and gait impairments in patients with multiple sclerosis and Parkinson's disease: A systematic review and meta-analysis. Gait & posture. vol 51. 2017-12-15. PMID:27756056. |
furthermore, among the primary outcome measures cop displacement and cop velocity, no evidence of an effect was found as well (subtotals multiple sclerosis: smd 0.07, 95% ci -0.15 to 0.28; smd -0.08, 95% ci -0.55 to 0.39). |
2017-12-15 |
2023-08-13 |
Not clear |
| Kim A Meijer, Anand J C Eijlers, Linda Douw, Bernard M J Uitdehaag, Frederik Barkhof, Jeroen J G Geurts, Menno M Schoonhei. Increased connectivity of hub networks and cognitive impairment in multiple sclerosis. Neurology. vol 88. issue 22. 2017-06-05. PMID:28468841. |
to investigate default-mode network (dmn) and frontoparietal network (fpn) dysfunction in cognitively impaired (ci) patients with multiple sclerosis (ms) because these networks strongly relate to cognition and contain most of the hubs of the brain. |
2017-06-05 |
2023-08-13 |
Not clear |
| Y C Lai, Y W Yew, W C Lamber. Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology : JEADV. vol 30. issue 12. 2017-04-21. PMID:27599898. |
patients with bp were significantly more likely to have stroke (rr 2.68, 95% ci: 2.07-3.46), parkinson's disease (pd; rr 3.42, 95% ci: 3.01-3.87), dementia (rr 4.46, 95% ci: 3.23-6.16), epilepsy (rr 2.98, 95% ci: 1.42-6.28), multiple sclerosis (rr 12.40, 95% ci: 6.64-23.17) and any aforementioned neurological disease (rr 4.93, 95% ci: 3.62-6.70), compared to controls. |
2017-04-21 |
2023-08-13 |
Not clear |
| Xiaofei Zhang, Fangfang Zhang, Dehui Huang, Lei Wu, Lin Ma, Hua Liu, Yujun Zhao, Shengyuan Yu, Jiong Sh. Contribution of Gray and White Matter Abnormalities to Cognitive Impairment in Multiple Sclerosis. International journal of molecular sciences. vol 18. issue 1. 2017-04-06. PMID:28035997. |
patients with multiple sclerosis (ms) commonly exhibit cognitive impairments (ci). |
2017-04-06 |
2023-08-13 |
Not clear |
| Emanuele D'Amico, Carmela Leone, Tumani Hayrettin, Francesco Patt. Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal. Multiple sclerosis (Houndmills, Basingstoke, England). vol 22. issue 5. 2016-12-22. PMID:26920381. |
cognitive impairment (ci) has been shown to be severe in patients with progressive forms of multiple sclerosis (ms), and the most frequently impaired domains are sustained attention, information processing speed, memory, and executive functions. |
2016-12-22 |
2023-08-13 |
Not clear |
| Nataša Giedraitienė, Rasa Kizlaitienė, Gintaras Kaubry. The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration. Medical science monitor : international medical journal of experimental and clinical research. vol 21. 2016-09-19. PMID:26655632. |
background assessment of cognitive impairment (ci) in multiple sclerosis (ms) patients is very useful, but it requires time-consuming expert evaluation with specialized materials. |
2016-09-19 |
2023-08-13 |
human |
| Nataša Giedraitienė, Rasa Kizlaitienė, Gintaras Kaubry. The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration. Medical science monitor : international medical journal of experimental and clinical research. vol 21. 2016-09-19. PMID:26655632. |
the brief international cognitive assessment for multiple sclerosis (bicams) was created as a brief and specific instrument for the evaluation of ci. |
2016-09-19 |
2023-08-13 |
human |
| Y H Lee, S-C Ba. Association between functional CD24 polymorphisms and susceptibility to autoimmune diseases: A meta-analysis. Cellular and molecular biology (Noisy-le-Grand, France). vol 61. issue 8. 2016-09-14. PMID:26718436. |
meta-analysis by autoimmune disease type showed a significant association between the cd24 val allele and multiple sclerosis (ms) (or = 1.420, 95% ci = 1.239-1.628, p = 4.7 × 10-8) and systemic lupus erythematous (sle) (or = 1.282, 95% ci = 1.081-1.521, p = 0.004), but not crohn's disease (cd) (or = 1.003, 95% ci = 0.826-1.218, p = 0.974). |
2016-09-14 |
2023-08-13 |
Not clear |
| Tea Skaaby, Lise Lotte Nystrup Husemoen, Betina Heinsbæk Thuesen, Allan Linneber. Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease. Endocrine. vol 50. issue 1. 2016-06-20. PMID:25666936. |
the risk for a 10 nmol/l higher vitamin d was: for any autoimmune disease (hr = 0.94 % ci 0.90, 0.98); thyrotoxicosis (hr = 0.83, 95 % ci 0.72, 0.96); type 1 diabetes (hr = 0.95, 95 % ci 0.88, 1.02), multiple sclerosis (hr = 0.89, 95 % ci 0.74, 1.07), iridocyclitis (hr = 1.00, 95 % ci 0.86, 1.17); crohn's disease (hr = 0.95, 95 % ci 0.80, 1.13), ulcerative colitis (hr = 0.88, 95 % ci 0.75, 1.04); psoriasis vulgaris (hr = 0.99, 95 % ci 0.86, 1.13); seropositive rheumatoid arthritis (hr = 0.97, 95 % ci 0.89, 1.07), and polymyalgia rheumatica (hr = 0.94, 95 % ci 0.83, 1.06). |
2016-06-20 |
2023-08-13 |
human |
| Carmela Leone, Emanuele D'Amico, Sabina Cilia, Alessandra Nicoletti, Luigi Di Pino, Francesco Patt. Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS. BMC neurology. vol 13. 2016-06-17. PMID:23889853. |
cognitive impairment and "invisible symptoms" are not associated with ccsvi in ms. we investigated the association between chronic cerebrospinal venous insufficiency (ccsvi) and cognitive impairment (ci) in multiple sclerosis (ms). |
2016-06-17 |
2023-08-12 |
Not clear |